GlobeNewswire

ConnectWise Announces New Solutions Designed to Reduce Complexity, Improve Efficiency and Drive Revenue

Dela

ORLANDO, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ConnectWise© welcomed more than 3,500 attendees to IT Nation today and Arnie Bellini, Chief Executive Officer, shared details on ConnectWise's vision to help technology solution providers (TSPs) build efficiencies and drive growth across their critical practice areas. As an integrated suite that features over 200 third-party integrations, ConnectWise is well positioned to expand the ecosystem for TSPs and Bellini highlighted some of the recent offerings reinforcing that direction.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/694ab680-f928-4363-8c2f-d70bb8ee2573

Extending the Reach of ConnectWise Unite
Last week, ConnectWise unveiled a pilot program for ConnectWise Unite(TM), a new solution to help TSPs automate and streamline billing, while also providing cloud-based monitoring and management. ConnectWise Unite allows Cisco partners to access and manage all Cisco Spark, Cisco Meraki, Cisco Umbrella and Cisco Stealthwatch solutions from a single management console. TSPs can sign up for a free trial of ConnectWise Unite with Cisco, which runs through Jan. 1, 2018.

ConnectWise Unite is also designed for TSPs that use Amazon Web Services for their cloud-based management and billing of virtual machines and storage. ConnectWise Unite solutions are built on the same foundation as ConnectWise CloudConsole(TM), which provides ConnectWise partners with an all-in-one tool for Microsoft Office 365 and Microsoft Azure cloud services.

"Our focus and passion for more than 35 years has been to find ways for TSPs to increase their efficiency, enhance visibility into their businesses and grow their businesses," said Bellini. "ConnectWise Unite does just that by drastically reducing the complexity and costs of managing multiple cloud solutions, while giving businesses of all sizes the ability to quickly reap the business advantages of recurring revenues."

First Look at What's Coming in 2018 
Coming in 2018, the ConnectWise Developer Kit will be used to make it simple and fast to connect to the ConnectWise platform. It will allow development teams to quickly connect anything in the ecosystem to the ConnectWise platform. The ConnectWise Developer Kit will provide a single pane of glass that unites our ecosystem. Bellini said ConnectWise's ongoing commitment to ensuring TSPs can choose which solutions work best for their businesses is the driving factor behind the idea of the ConnectWise Developer Kit.

"We understand that one-size-fits-all solutions are not practical in an ever-evolving ecosystem as diverse as the one in which TSPs exist," he said. "Giving our partners the choice to seamlessly integrate any solution they prefer with the ConnectWise platform allows them to take advantage of the single pane of glass simplicity in a way that makes sense for their unique needs."

Craig Fulton, Chief Product Officer for ConnectWise, also took the stage during today's keynote to reveal several new enhancements and features of the ConnectWise suite.

ConnectWise Automate(TM) starts its transition to a web implementation, allowing for tighter integration between Automate and ConnectWise Manage(TM). The first two functions moving to the web are computer management and a new network map feature, both of which can be accessed from any device with a browser and without having to leave the service ticket.  These enhancements are expected to be available in the first quarter of 2018.

ConnectWise Perspective, an innovative addition to remote control functionality, will enable a smartphone video connection between a TSP's customer and a technician, and will relay a live video feed from that customer's smartphone to the technician. Available in the second quarter of 2018, Perspective will enhance service delivery by auto scanning barcodes, recording session time, adding workstation information into tickets and more.

"One of the many benefits of Perspective is what it means for our partners when it comes to training and staffing. Junior technicians can operate in the field with a senior technician's support back in the office," said Fulton. "Additionally, Perspective enables a customer to play the role of field technician, in conjunction with the communication back to a technician in the office."

IT Nation is the largest annual event in the technology solutions provider industry. The three-day conference in Orlando brings together representatives that sell, service and support technology from across the globe. This year's IT Nation runs through November 10.

Follow ConnectWise  
LinkedIn 
ConnectWise Blog  
Twitter  
Facebook 
YouTube 

About ConnectWise 
ConnectWise transforms how technology solution providers successfully build, manage, and grow their businesses. Our award-winning set of software solutions provide a fully integrated, seamless experience to companies in more than 50 countries, giving them the ability to increase their productivity, efficiency, and profitability. When combined with our relentless commitment to innovation, powerful network of ideas and experts, unparalleled passion for our users, and more than 35 years of experience, ConnectWise software solutions deliver the support companies want at each step of their business journey. For more information, visit www.ConnectWise.com.

Copyright © 2017 ConnectWise. All Rights Reserved. All trademarks, trade names, service marks and logos referenced herein belong to their respective companies. All other company, product, or service names may be trademarks or service marks of others and are the property of their respective owners. 

Media Contacts: 
Elizabeth Bassler
EBassler@ConnectWise.com
813.300.1292

Diane Rose for ConnectWise
diane@dkrcomms.com
727.238.7567




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ConnectWise via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum